Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
09/2014
09/25/2014US20140287029 Immunogenic epitopes of ngep antigen
09/25/2014US20140287002 Agonists Of Guanylate Cyclase And Their Uses
09/25/2014US20140287001 Compositions Useful For The Treatment Of Gastrointestinal Disorders
09/25/2014US20140286952 Inhibitors of Metastasis, Methods of Generating Such Inhibitors and Their Therapeutic Applications
09/25/2014US20140286888 Self-assembling peptide and peptide gel with high strength
09/25/2014US20140286864 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
09/24/2014EP2780358A1 Cyclosporine a form 2 and method of making same
09/24/2014EP2780357A1 Polymyxin derivatives
09/24/2014EP2780039A2 Cytotoxic peptides and antibody drug conjugates thereof
09/24/2014EP2780029A1 Oral leptin formulations and uses thereof
09/23/2014US8841420 Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with Porphyromonas gingivalis
09/23/2014US8841413 Antidiabetic compounds
09/23/2014US8841083 PSA capture agents, compositions, methods and preparation thereof
09/23/2014US8839962 Separation and/or purification of B0 from C0
09/18/2014WO2014145389A1 Inhibition of pulmonary fibrosis with nutlin-3a and peptides
09/18/2014WO2014144793A1 Substituted silaxanthenium red to near-infrared fluorochromes for in vitro and in vivo imaging and detection
09/18/2014WO2014144260A1 Peptide compositions
09/18/2014WO2014142764A1 New stable pentadecapeptide salts, a process for preparation thereof, a use thereof in the manufacture of pharmaceutical preparations and a use thereof in therapy
09/18/2014WO2014142357A1 Treating agent for plant cell walls, substance delivery method using treating agent, and substance delivery system
09/18/2014WO2014142102A1 Liquid aqueous composition
09/18/2014WO2014141652A1 Smyd3 peptides and vaccines containing the same
09/18/2014WO2014139476A1 Epitope of rsv fusion protein and antibody identifying same
09/18/2014WO2014139472A1 Compositions and methods of using islet neogenesis peptides and analogs thereof
09/18/2014WO2014139182A1 Compositions and methods of using islet neogenesis peptides and analogs thereof
09/18/2014US20140275479 Specific binding agents of human angiopoeitin-2
09/18/2014US20140274916 Cyclic peptoid oligomers, pharmaceutical compositions and methods of using the same
09/18/2014US20140274906 Nd2 peptides and methods of treating neurological disease
09/18/2014US20140274904 Inhibitors of mitochondrial fission and methods of use thereof
09/18/2014US20140274887 Compounds for Control of Appetite
09/18/2014US20140274884 Inhibitors of hepatitis c virus
09/18/2014US20140274883 Novel antiviral compounds from marine extracts
09/18/2014US20140274790 IgG-BINDING PEPTIDE AND METHOD FOR DETECTING AND PURIFYING IgG USING SAME
09/18/2014US20140271693 Aqueous liquid composition
09/18/2014US20140271692 Novel immunogenic epitopes for immunotherapy
09/18/2014US20140271652 Immunologically active polypeptide
09/17/2014EP2778176A1 Compositions and methods for analyzing histidine phosphorylation
09/17/2014EP2776471A1 Stable peptide-based furin inhibitors
09/17/2014EP2776451A1 Cyclin a1-targeted t-cell immunotherapy for cancer
09/17/2014EP2776055A1 Treatments for gastrointestinal disorders
09/16/2014US8835605 Uses of cancer-targeting peptides in cancer diagnosis
09/16/2014US8835603 Agents for the treatment of celiac disease
09/16/2014US8835395 Protein peptide hydrogels
09/16/2014US8835377 Oral delivery of peptide pharmaceutical compositions
09/16/2014US8835375 Cyclic angiotensin analogs
09/16/2014US8835361 High-throughput quantitation of crop seed proteins
09/16/2014US8835172 Modular functional peptides for delivery of nanoparticles
09/16/2014CA2675202C Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
09/12/2014WO2014137572A1 Regulation of specific spinal neurons regulating pain transmission
09/12/2014WO2014137496A1 Mu opioid receptor agonist analogs of the endomorphins
09/12/2014WO2014137355A1 Anti-cxcl13 antibodies and associated epitope sequences
09/12/2014WO2014135282A1 Amatoxin derivatives
09/11/2014US20140259231 Multi-Gene Expression Vehicle
09/11/2014US20140256912 Stabilized Variant MAML Peptides and Uses Thereof
09/11/2014US20140256648 Hjurp peptides and vaccines including the same
09/11/2014US20140256646 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents
09/11/2014US20140256645 Extract and peptides derived from oryza sativa japonica group and uses thereof
09/11/2014US20140256639 Peptoid neutralizing agents
09/11/2014US20140256638 Peptoid neutralizing agents
09/11/2014US20140256634 Treatments for Gastrointestinal Disorders
09/11/2014US20140256628 Compositions And Methods For Treating Glioma
09/11/2014US20140256625 Anti-amyloidogenic, alpha-helix breaking ultra-small peptide therapeutics
09/11/2014US20140256614 Compositions and methods for augmenting permeability barriers
09/11/2014US20140256596 Modulation of structured polypeptide specificity
09/11/2014US20140256038 Peptide-Bound Gold Metal Nano-clusters as Cancer Cell Killing Agents
09/11/2014US20140255437 Topk peptides and vaccines including the same
09/11/2014US20140255383 Recombinant human naglu protein and uses thereof
09/11/2014US20140255361 Estrogen-receptor based ligand system for regulating protein stability
09/11/2014US20140255299 Methods and Compositions Comprising a C-Terminal Bax Peptide
09/10/2014EP2774624A1 Amatoxin derivatives
09/10/2014EP2773653A1 Fluorescent substrates for determining lysine modifying enzyme activity
09/10/2014EP2773427A2 Medical use
09/10/2014EP2773366A1 Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
09/09/2014US8829159 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
09/09/2014US8829158 Peptides, derivatives and analogs thereof, and methods of using same
09/09/2014US8829157 Process for the synthesis of cyclic heptapeptide
09/09/2014US8828942 Means for treating synucleinopathies
09/09/2014US8828938 Method for the manufacture of degarelix
09/09/2014US8828929 Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereof
09/09/2014US8828928 Amphiphilic peptides and peptide particles
09/09/2014US8828926 Uses of natriuretic peptide constructs
09/09/2014US8828413 Peptoid oligomers, pharmaceutical compositions and methods of using the same
09/09/2014US8828401 Cytotoxic peptides and antibody drug conjugates thereof
09/09/2014US8828389 Methods of diagnosing ALS
09/04/2014WO2014134561A2 Quantification of vaccine compositions
09/04/2014WO2014132084A1 Non-immunosuppressive cyclosporin derivatives as antiviral agents
09/04/2014WO2014131856A1 Treatment of neonatal alloimmune thrombocytopenia
09/04/2014US20140249293 Absent and Rare Peptides and Therapeutic Uses Thereof
09/04/2014US20140249073 Broad spectrum antibiotics
09/04/2014US20140248660 Heterologous intron within a signal peptide
09/04/2014US20140248633 Leukemia stem cell targeting ligands and methods of use
09/04/2014US20140248603 Quantification of vaccine compositions
09/03/2014EP2771351A1 Pat-lm1 epitopes and methods for using same
09/03/2014EP2771350A1 Topk peptides and vaccines including the same
09/02/2014US8822638 Procoagulant peptides
09/02/2014US8822637 Somatostatin analogues
09/02/2014US8822422 Antitumor agent
09/02/2014US8822420 Peptides and aptamers thereof as specific modulators of mutant p53 function
09/02/2014US8822406 Tumor activated prodrugs
09/02/2014CA2736974C Tumour-associated peptides that bind to mhc molecules
08/2014
08/28/2014WO2014130408A1 Regulators of rab5 activity
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 423